Shockwave Medical Inc
NASDAQ:SWAV
Shockwave Medical Inc
NASDAQ:SWAV
Price:
330.54 USD
-0.03%
Market Closed
Updated:
May 10, 2024
Shockwave Medical Inc
Cost of Revenue
|
Shockwave Medical Inc
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Cost of Revenue
-$95.4m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Shockwave Medical Inc's Cost of Revenue?
Cost of Revenue
-95.4m
USD
-95.4m
USD
Based on the financial report for Dec 31, 2023, Shockwave Medical Inc's Cost of Revenue amounts to -95.4m USD.
What is Shockwave Medical Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-67%
-67%
Over the last year, the Cost of Revenue growth was -47%. The average annual Cost of Revenue growth rates for Shockwave Medical Inc have been -66% over the past three years , -67% over the past five years .
You don't have any saved screeners yet
